2020
DOI: 10.1016/j.cca.2020.06.021
|View full text |Cite
|
Sign up to set email alerts
|

Analytical performance of cardiac troponin assays – Current status and future needs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 65 publications
1
3
0
Order By: Relevance
“…RCV combine within-individual biological variation, analytical variation and a z-value to give an estimate of random variation when two consecutive results are compared. Earlier studies have shown that the long-term within-individual biological variation of troponins is approximately 15% (32). The analytical variation at the low concentrations measured in our study was approximately 10% (see above).…”
Section: Discussionsupporting
confidence: 61%
“…RCV combine within-individual biological variation, analytical variation and a z-value to give an estimate of random variation when two consecutive results are compared. Earlier studies have shown that the long-term within-individual biological variation of troponins is approximately 15% (32). The analytical variation at the low concentrations measured in our study was approximately 10% (see above).…”
Section: Discussionsupporting
confidence: 61%
“…Along with the introduction and application of high-sensitivity assays with much lower detectable concentration capability, a higher proportion of athletes were detected or tested positive for elevations in high-sensitivity cardiac troponin (hs-cTn) prior to and following exercise (Gresslien and Agewall, 2016). Since hs-cTn has been interpreted as a quantitative assessment for cardiomyocyte damage (Collet et al, 2020), with even lowlevel elevations in healthy populations used to predict further cardiovascular risks associated with chronic myocardial injury (Seliger et al, 2017;Aakre et al, 2020), it is necessary to reconsider our understanding of the underlying mechanisms and clinical implications related to hs-cTn elevations following exercise in athletes.…”
Section: Introductionmentioning
confidence: 99%
“…Although the regulatory documents concerning the diagnostics and treatment of different forms of acute coronary syndrome and myocardial infarction contain clear recommendations on the time of troponin testing and decision-making levels, and the sensitivity and specificity of most immunoassays approximates 100%, there still remains a number of unsolved problems and issues relating to the application of these markers in clinical practice. Some of these problems are connected with the variety of troponin diagnostic agents, their unequal sensitivity and diagnostic accuracy, different susceptibility to cross-reactive substances (molecules), i.e., with different analytical characteristics of test systems [ 14 , 16 , 17 ]. Another range of issues results from the fact that the increase in cardiac troponin levels takes place in case of myocardial necrosis of any etiology and sometimes in the absence of irreversible myocardial injury (for instance, in case of reversible injury induced by physical exercises, renal failure, or the influence of false-positive factors) [ 18 24 ].…”
Section: Introductionmentioning
confidence: 99%